Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company ...

Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company with a market capitalization of $5.2 billion focused on developing novel therapies for central nervous system (CNS) disorders, has ...

This transaction also marks Avendus Future Leaders Fund's (FLF's)first investment in its newly launched Future Leaders Fund ...

A map of deadly infectious diseases known to attack the central nervous system (CNS) of people who are already suffering with ...

Area briefs about ceremonies Jan. 28 for CNS Cares in Oak Ridge and a behavioral health company in Rocky Top, formerly known as Lake City.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurosense Therapeutics Ltd. (NRSN – Research Report), ...

Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, ...

Separately, Rakovina Therapeutics expects to receive the first synthesized drug candidates from its second AI-driven drug discovery program targeting ATR.

Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service (DDoS) protection specialists, today announced new advancements in multi-site resiliency and intelligent traffic ...

Avendus Future Leaders Fund (FLF), has acquired a minority stake in La Renon Healthcare Pvt. Ltd, a domestic branded ...